Skip to main content

Table 1 Morphometric and demographic data and surgical procedures

From: Early administration of levosimendan is associated with improved kidney function after cardiac surgery – a retrospective analysis

  Levo OR Levo ICU Pvalue
(n = 28) (n = 18)
Age (years) 66 ± 10 67 ± 11 0.535
Weight (kg) 82.1 ± 15.9 81.5 ± 15.0 0.928
Height (m) 1.76 ± 0.1 1.72 ± 0.1 0.167
Body mass index (kg/m2) 26.3 ± 3.9 27.9 ± 5.0 0.286
Sex (men/women) 22/6 13/5 0.622
Procedure    
CABG 15 5 0.114
VR 5 8 0.051
CABG + VR 8 5 0.953
NYHA III/IV 25 16 0.966
Coronary artery disease 23 13 0.426
LVEF (%) 31 ± 12 36 ± 15 0.233
COPD 9 5 0.754
Peripheral vascular disease 7 5 0.834
Atrial fabrillation 17 9 0.474
Hyperlipidaemia 8 8 0.270
Nicotine abuse 6 1 0.144
Pulmonary arterial hypertension 12 10 0.400
Arterial hypertension 13 9 0.813
Diabetes mellitus 16 12 0.518
  1. Data are expressed as mean ± SD, numbers or percentage. CABG, coronary arterial bypass grafting; VR, valve reconstrution and/or replacement; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease.